Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapyLeri S. Faried(Gunma University), Takashi Minegishi(Gunma University)Oncology ReportsJuly 1, 200610.3892/or.16.1.57Cited by 57SaveCiteExport RISWatch citationsRelated PapersEffect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor|BMC Cancer|2015|21